RELMADA THERAPEUTICS, INC. Interest and Other Income
RELMADA THERAPEUTICS, INC. (RLMD) reported Interest and Other Income of $1.29 million for the 3-month period ending 2023-03-31, per its 10-Q filed 2023-05-11.
Discontinued › Income Statement › Other Income
us-gaap:InterestAndOtherIncome · last filed 2023-05-11
- RELMADA THERAPEUTICS, INC. interest and other income for the quarter ending 2023-03-31 was $1.29M.
- RELMADA THERAPEUTICS, INC. interest and other income for fiscal 2021 was $0.00.
| Period end | Interest and Other Income 3 month | Interest and Other Income 12 month | Interest and Other Income 12 month as first filed |
|---|---|---|---|
| 2023-03-31 | $1.29M 10-Q · filed 2023-05-11 | ||
| 2022-12-31 | $1.76M 10-Q · filed 2023-05-11 | $6.35M 10-K · filed 2023-03-23 | |
| 2021-12-31 | $0.00 10-K · filed 2023-03-23 |
Similar stocks
| Stock Name | Country | Market Cap | PE Ratio |
|---|---|---|---|
| Opus Genetics, Inc. (IRD) | United States | $0.406B | -3.16 |
| Arcturus Therapeutics Holdings Inc. (ARCT) | $0.402B | -2.05 | |
| GALECTIN THERAPEUTICS INC (GALT) | United States | $0.399B | -11.06 |
| ARS Pharmaceuticals, Inc. (SPRY) | United States | $0.414B | -3.70 |
| Atea Pharmaceuticals, Inc. (AVIR) | United States | $0.414B | -2.26 |
| Turn Therapeutics Inc. (TTRX) | United States | $0.397B | -25.68 |
| DiaMedica Therapeutics Inc. (DMAC) | United States | $0.423B | -10.11 |
| PROTHENA CORP PUBLIC LTD CO (PRTA) | Ireland | $0.428B | -11.53 |
| Rezolute, Inc. (RZLT) | United States | $0.382B | -6.45 |
| CYPHERPUNK TECHNOLOGIES INC. (CYPH) | United States | $0.438B | -75.63 |